rekambys
janssen-cilag international nv - rilpivirine - hiv-infeksjoner - antivirale midler til systemisk bruk - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.
calcium-sandoz 500 mg
sandoz - københavn - kalsiumkarbonat / kalsiumlaktatglukonat - brusetablett - 500 mg
omnic 0.4 mg
astellas pharma (1) - tamsulosinhydroklorid - depottablett - 0.4 mg
prograf 0.5 mg
astellas pharma a/s - takrolimusmonohydrat - kapsel, hard - 0.5 mg
prograf 1 mg
astellas pharma a/s - takrolimusmonohydrat - kapsel, hard - 1 mg
prograf 5 mg
astellas pharma a/s - takrolimusmonohydrat - kapsel, hard - 5 mg
prograf 5 mg/ ml
astellas pharma a/s - takrolimus - konsentrat til infusjonsvæske, oppløsning - 5 mg/ ml
urizia 6 mg / 0.4 mg
astellas pharma a/s - solifenacinsuksinat / tamsulosinhydroklorid - tablett med modifisert frisetting - 6 mg / 0.4 mg
vesicare 5 mg
astellas pharma - kastrup - solifenacinsuksinat - tablett, filmdrasjert - 5 mg
vesicare 10 mg
astellas pharma - kastrup - solifenacinsuksinat - tablett, filmdrasjert - 10 mg